755 results on '"Schreiber, Stuart L"'
Search Results
2. Assigning functionality to cysteines by base editing of cancer dependency genes
3. DNA-encoded library-enabled discovery of proximity-inducing small molecules
4. Molecular glues and bifunctional compounds: Therapeutic modalities based on induced proximity
5. Author Correction: Diversity-oriented synthesis encoded by deoxyoligonucleotides
6. Diversity-oriented synthesis encoded by deoxyoligonucleotides
7. Reference compounds for characterizing cellular injury in high-content cellular morphology assays
8. Mapping the landscape of genetic dependencies in chordoma
9. An expanded universe of cancer targets.
10. Beth Levine in memoriam
11. Bicyclic azetidines target acute and chronic stages of Toxoplasma gondii by inhibiting parasite phenylalanyl t-RNA synthetase
12. PALP: A rapid imaging technique for stratifying ferroptosis sensitivity in normal and tumor tissues in situ
13. Bicyclic Pyrrolidine Inhibitors of Toxoplasma gondii Phenylalanine t-RNA Synthetase with Antiparasitic Potency In Vitro and Brain Exposure
14. The Use of Informer Sets in Screening: Perspectives on an Efficient Strategy to Identify New Probes
15. A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
16. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
17. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
18. Targeted brachyury degradation disrupts a highly specific autoregulatory program controlling chordoma cell identity
19. Recent achievements and current trajectories of diversity-oriented synthesis
20. Progress in Understanding Ferroptosis and Challenges in Its Targeting for Therapeutic Benefit
21. Towards a treatment for genetic prion disease: trials and biomarkers
22. Chemical tools to expand the ligandable proteome: diversity-oriented synthesis-based photoreactive stereoprobes
23. Bicyclic pyrrolidine inhibitors ofToxoplasma gondiiphenylalanine t-RNA synthetase with antiparasitic potencyin vitroand brain exposure
24. High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines
25. High-Throughput Assay and Discovery of Small Molecules that Interrupt Malaria Transmission
26. Modular, stereocontrolled C β –H/C α –C activation of alkyl carboxylic acids
27. Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development
28. Structural basis of malaria parasite phenylalanine tRNA-synthetase inhibition by bicyclic azetidines
29. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion
30. Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles
31. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis
32. The promise and peril of chemical probes
33. Linking Tumor Mutations to Drug Responses via a Quantitative Chemical–Genetic Interaction Map
34. Proteomic Ligandability Maps of Spirocycle Acrylamide Stereoprobes Identify Covalent ERCC3 Degraders.
35. Bifunctional Small Molecules That Induce Nuclear Localization and Targeted Transcriptional Regulation
36. Chemical Proteomic Discovery of Isotype‐Selective Covalent Inhibitors of the RNA Methyltransferase NSUN2
37. Rational Screening for Cooperativity in Small-Molecule Inducers of Protein–Protein Associations
38. The landscape of cancer cell line metabolism
39. Small-molecule targeting of brachyury transcription factor addiction in chordoma
40. Small-molecule inhibitors directly target CARD9 and mimic its protective variant in inflammatory bowel disease
41. Chemical probes and drug leads from advances in synthetic planning and methodology
42. Proposed Resolution of a Mechanistic Puzzle of Long Duration: Self-Condensation of Cyclopentanone to Form an 11-Carbon Dienoic Acid
43. Suppl. Figure S12 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
44. Suppl.Figure S16 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
45. Table ST9 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
46. Supplementary Data from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
47. Supplementary Table S5 from Linking Tumor Mutations to Drug Responses via a Quantitative Chemical–Genetic Interaction Map
48. Data from Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset
49. Supplementary Methods, Table Legends, Figures 1 - 7 from Linking Tumor Mutations to Drug Responses via a Quantitative Chemical–Genetic Interaction Map
50. Supplmental Figures S1 - S8 from Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.